Exicure, Inc.(XCUR)Earnings, Financials & Key Ratios
XCUR•NASDAQ
$3.39
$22M mkt cap·Price updated May 6, 2026
AboutExicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.Show more
- Revenue$500K
- EBITDA-$11M+16.2%
- Net Income-$10M+42.6%
- EPS (Diluted)-1.59+24.6%
- Gross Margin100%
- EBITDA Margin-2281.6%
- Operating Margin-2446.4%
- Net Margin-1940.2%
- ROE-197.92%-5.0%
- ROIC-202.09%-102.4%
- Debt/Equity0.88-60.1%
- Interest Coverage-679.56
XCUR Key Insights
Exicure, Inc. (XCUR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓Share count reduced 23.8% through buybacks
- ✓Healthy 5Y average net margin of 2793.5%
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 11 (bottom 11%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Sales declining 17.3% over 5 years
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
XCUR Price & Volume
Exicure, Inc. (XCUR) stock price & volume — 10-year historical chart
Loading chart...
XCUR Growth Metrics
Exicure, Inc. (XCUR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-17.34%
3 Years-
TTM-100%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-130.32%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-209.15%
Return on Capital
10 Years-74.24%
5 Years-71.38%
3 Years-73.56%
Last Year-116.19%
XCUR Peer Comparison
Exicure, Inc. (XCUR) competitors in RNA and Genome Editing Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SRPT | 2.42B | 23.03 | -3.23 | 15.58% | 2.98% | 4.89% | 0.91 | |
 ARWR | 11.08B | 79.14 | -6486.89 | 232.58% | 18.54% | 35.64% | 0.73 | |
 NTLA | 1.61B | 13.85 | -3.64 | -100% | -61.47% | 0.14 | ||
 BEAM | 3.32B | 32.33 | -39.92 | 120.01% | -57.24% | -7.31% | 0.24 | |
 EDIT | 310.73M | 3.18 | -1.76 | -100% | -5.23% | 0.66 | ||
 CRSP | 5.31B | 55.08 | -8.51 | -89.97% | -138.57% | -30.88% | 0.21 | |
 IONS | 12.7B | 76.85 | -32.29 | 33.87% | -30.87% | -58.57% | 5.35 | |
 REGN | 74.89B | 720.78 | 17.38 | 0.99% | 29.65% | 14.32% | 0.09 |
Compare XCUR vs Peers
Exicure, Inc. (XCUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
XCUR Income Statement
Exicure, Inc. (XCUR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.04M | 9.72M | 118K | 1.3M | 16.61M | -483K | 28.83M | 0 | 500K | 0 |
| Revenue Growth % | -56.62% | 838.13% | -98.79% | 998.31% | 1181.87% | -102.91% | 6068.12% | -100% | - | -100% |
| Cost of Goods Sold | 13.66M | 13.08M | 14.12M | 0 | 32.09M | 0 | 1.86M | 1.42M | 0 | 0 |
| COGS % of Revenue | 1318.44% | 134.58% | 11965.25% | - | 193.19% | - | 6.44% | - | - | - |
| Gross Profit | -12.62M▲ 0% | -3.36M▲ 73.4% | -14M▼ 316.6% | 1.3M▲ 109.3% | -15.48M▼ 1294.5% | -483K▲ 96.9% | 26.97M▲ 5683.9% | -1.42M▼ 105.3% | 500K▲ 135.1% | 0▲ 0% |
| Gross Margin % | -1218.44% | -34.58% | -11865.25% | 100% | -93.19% | 100% | 93.56% | - | 100% | - |
| Gross Profit Growth % | -63.17% | 73.37% | -316.57% | 109.26% | -1294.52% | 96.88% | 5683.85% | -105.28% | 135.14% | - |
| Operating Expenses | 17.2M | 20.13M | 21.94M | 27.91M | 9.96M | 62.07M | 28.8M | 13.57M | 12.73M | 9.54M |
| OpEx % of Revenue | 1660.04% | 207.08% | 18590.68% | 2153.78% | 59.92% | -12850.1% | 99.91% | - | 2546.4% | - |
| Selling, General & Admin | 3.54M | 7.05M | 7.82M | 8.57M | 9.96M | 13.09M | 10.89M | 12.65M | 5.45M | 6.67M |
| SG&A % of Revenue | 341.6% | 72.5% | 6625.42% | 661.5% | 59.92% | -2709.52% | 37.78% | - | 1089.8% | - |
| Research & Development | 13.66M | 13.08M | 14.12M | 19.34M | 32.09M | 48.98M | 19.77M | 1.42M | 0 | 2.63M |
| R&D % of Revenue | 1318.44% | 134.58% | 11965.25% | 1492.28% | 193.19% | -10140.58% | 68.57% | - | - | - |
| Other Operating Expenses | -55K | 191K | -249K | 0 | -32.09M | 0 | -1.86M | -503K | 7.28M | 64K |
| Operating Income | -16.16M▲ 0% | -10.41M▲ 35.6% | -21.82M▼ 109.7% | -26.62M▼ 22.0% | -25.44M▲ 4.4% | -62.55M▼ 145.9% | -1.83M▲ 97.1% | -15M▼ 719.0% | -12.23M▲ 18.4% | -9.54M▲ 0% |
| Operating Margin % | -1560.04% | -107.08% | -18490.68% | -2053.78% | -153.11% | 12950.1% | -6.35% | - | -2446.4% | - |
| Operating Income Growth % | -22.96% | 35.61% | -109.66% | -21.99% | 4.44% | -145.91% | 97.07% | -719.01% | 18.43% | - |
| EBITDA | -15.98M | -10.18M | -21.46M | -25.89M | -23.99M | -60.77M | 25K | -13.62M | -11.41M | -9.02M |
| EBITDA Margin % | -1542.66% | -104.69% | -18187.29% | -1997.92% | -144.4% | 12581.78% | 0.09% | - | -2281.6% | - |
| EBITDA Growth % | -22.83% | 36.33% | -110.92% | -20.65% | 7.35% | -153.32% | 100.04% | -54584% | 16.25% | -69.19% |
| D&A (Non-Cash Add-back) | 180K | 232K | 358K | 724K | 1.45M | 1.78M | 1.86M | 1.38M | 824K | 519K |
| EBIT | -16.22M | -10.22M | -21.74M | -25.52M | -24.09M | -62.41M | -1.78M | -16.91M | -9.68M | -15.09M |
| Net Interest Income | -724K | -795K | -668K | -608K | 399K | -1.55M | -580K | 32K | -10K | 39K |
| Interest Income | 0 | 0 | 4K | 178K | 972K | 141K | 15K | 32K | 8K | 39K |
| Interest Expense | 724K | 795K | 672K | 786K | 573K | 1.69M | 595K | 0 | 18K | 0 |
| Other Income/Expense | -779K | -604K | -594K | 314K | 768K | -1.55M | -542K | -1.92M | 2.54M | 311K |
| Pretax Income | -16.94M▲ 0% | -11.01M▲ 35.0% | -22.41M▼ 103.6% | -26.3M▼ 17.4% | -24.67M▲ 6.2% | -64.1M▼ 159.9% | -2.37M▲ 96.3% | -16.91M▼ 612.8% | -9.69M▲ 42.7% | -9.23M▲ 0% |
| Pretax Margin % | -1635.23% | -113.29% | -18994.07% | -2029.55% | -148.49% | 13271.64% | -8.23% | - | -1938.6% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 209K | 0 | 8K | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | -8.81% | 0% | -0.08% | 0% |
| Net Income | -16.94M▲ 0% | -11.01M▲ 35.0% | -22.41M▼ 103.6% | -26.3M▼ 17.4% | -24.67M▲ 6.2% | -64.1M▼ 159.9% | -2.58M▲ 96.0% | -16.91M▼ 555.1% | -9.7M▲ 42.6% | -9.23M▲ 0% |
| Net Margin % | -1635.23% | -113.29% | -18994.07% | -2029.55% | -148.49% | 13271.64% | -8.96% | - | -1940.2% | - |
| Net Income Growth % | -28.82% | 35% | -103.55% | -17.36% | 6.22% | -159.86% | 95.97% | -555.07% | 42.65% | -130.32% |
| Net Income (Continuing) | -16.94M | -11.01M | -22.41M | -26.3M | -24.67M | -64.1M | -2.58M | -16.91M | -9.7M | -9.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -12.88▲ 0% | -8.37▲ 35.0% | -16.32▼ 95.0% | -13.68▲ 16.2% | -8.49▲ 37.9% | -21.70▼ 155.6% | -0.56▲ 97.4% | -2.11▼ 276.8% | -1.59▲ 24.6% | -1.46▲ 0% |
| EPS Growth % | -28.29% | 35.02% | -94.98% | 16.18% | 37.94% | -155.59% | 97.42% | -276.79% | 24.64% | -209.15% |
| EPS (Basic) | -12.93 | -8.37 | -16.32 | -13.68 | -8.49 | -21.70 | -0.56 | -2.11 | -1.59 | - |
| Diluted Shares Outstanding | 1.32M | 1.32M | 1.37M | 1.92M | 2.91M | 2.95M | 4.62M | 8.01M | 6.1M | 6.32M |
| Basic Shares Outstanding | 1.31M | 1.32M | 1.37M | 1.92M | 2.91M | 2.95M | 4.62M | 8.01M | 6.1M | 6.32M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
XCUR Balance Sheet
Exicure, Inc. (XCUR) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 20.04M | 27.64M | 27.66M | 112.78M | 86.32M | 43.67M | 10.05M | 2.02M | 13.67M | 5.44M |
| Cash & Short-Term Investments | 19.62M | 25.76M | 26.27M | 110.79M | 82.08M | 39.14M | 8.58M | 816K | 12.51M | 4.44M |
| Cash Only | 19.62M | 25.76M | 26.27M | 48.46M | 33.26M | 34.64M | 8.58M | 816K | 12.51M | 4.44M |
| Short-Term Investments | 0 | 0 | 0 | 62.33M | 48.82M | 4.5M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 15K | 30K | 3K | 35K | 11K | 0 | 0 | 250K | 521K | 55K |
| Days Sales Outstanding | 5.28 | 1.13 | 9.28 | 9.86 | 0.24 | - | - | - | 380.33 | - |
| Inventory | 0 | 0 | 646K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | 16.7 | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 746K | 0 | 1.2M | 1.28M | 853K | 24K | 69K | 946K |
| Total Non-Current Assets | 535K | 1.35M | 1.09M | 2.49M | 14.12M | 21.2M | 13.28M | 9.56M | 1.38M | 9.83M |
| Property, Plant & Equipment | 503K | 1.32M | 1.06M | 2.46M | 12.73M | 11.88M | 9.79M | 6.57M | 26K | 816K |
| Fixed Asset Turnover | 2.06x | 7.38x | 0.11x | 0.53x | 1.31x | -0.04x | 2.95x | - | 19.23x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.34M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.78M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1.2M | 1.2M | 0 | 0 |
| Other Non-Current Assets | 32K | 32K | 32K | 32K | 1.39M | 9.32M | 2.29M | 1.78M | 1.36M | 6.69M |
| Total Assets | 20.58M▲ 0% | 28.99M▲ 40.9% | 28.76M▼ 0.8% | 115.26M▲ 300.8% | 100.44M▼ 12.9% | 64.87M▼ 35.4% | 23.33M▼ 64.0% | 11.58M▼ 50.4% | 15.06M▲ 30.0% | 15.27M▲ 0% |
| Asset Turnover | 0.05x | 0.34x | 0.00x | 0.01x | 0.17x | -0.01x | 1.24x | - | 0.03x | 0.00x |
| Asset Growth % | 4.87% | 40.88% | -0.8% | 300.83% | -12.86% | -35.42% | -64.04% | -50.36% | 30.02% | 242.02% |
| Total Current Liabilities | 12.16M | 3.36M | 2.04M | 31.09M | 13.73M | 34.07M | 1.64M | 2.51M | 3.07M | 2.77M |
| Accounts Payable | 509K | 1.05M | 500K | 1.81M | 1.87M | 3.41M | 361K | 1.63M | 1.03M | 1.31M |
| Days Payables Outstanding | 13.6 | 29.27 | 12.93 | - | 21.22 | - | 70.99 | 418.35 | - | - |
| Short-Term Debt | 1.21M | 0 | 0 | 4.96M | 0 | 6.87M | 539K | 0 | 0 | 340K |
| Deferred Revenue (Current) | 8.28M | 1.03M | 0 | 21.87M | 0 | 17.32M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 1.22M | 8.34M | 0 | 707K | 0 | 0 | 0 |
| Current Ratio | 1.65x | 8.24x | 13.54x | 3.63x | 6.29x | 1.28x | 6.13x | 0.81x | 4.45x | 4.45x |
| Quick Ratio | 1.65x | 8.24x | 13.22x | 3.63x | 6.29x | 1.28x | 6.13x | 0.81x | 4.45x | 4.45x |
| Cash Conversion Cycle | - | - | 13.05 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 5.97M | 5.66M | 5.76M | 3.43M | 25.2M | 19.57M | 6.77M | 6.04M | 5.21M | 5.57M |
| Long-Term Debt | 4.45M | 4.86M | 4.92M | 0 | 16.59M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | -201K | 0 | 0 | 59K | 7.96M | 7.4M | 6.77M | 6.04M | 5.21M | 5.27M |
| Deferred Tax Liabilities | 201K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 281K | 801K | 836K | 414K | 656K | 656K | 0 | 0 | 0 | 16.23M |
| Total Liabilities | 18.13M | 9.01M | 7.8M | 34.52M | 38.94M | 53.64M | 8.41M | 8.55M | 8.28M | 8.34M |
| Total Debt | 5.67M | 4.86M | 4.92M | 5.32M | 24.77M | 14.74M | 7.31M | 6.67M | 5.93M | 366K |
| Net Debt | -13.96M | -20.91M | -21.34M | -43.14M | -8.49M | -19.91M | -1.27M | 5.85M | -6.57M | -4.07M |
| Debt / Equity | 2.31x | 0.24x | 0.24x | 0.07x | 0.40x | 1.31x | 0.49x | 2.20x | 0.88x | 0.88x |
| Debt / EBITDA | - | - | - | - | - | - | 292.24x | - | - | -0.04x |
| Net Debt / EBITDA | - | - | - | - | - | - | -50.84x | - | - | 0.45x |
| Interest Coverage | -22.32x | -13.09x | -32.47x | -33.86x | -44.39x | -36.99x | -3.08x | - | -679.56x | - |
| Total Equity | 2.45M▲ 0% | 19.98M▲ 716.0% | 20.95M▲ 4.9% | 80.75M▲ 285.4% | 61.51M▼ 23.8% | 11.23M▼ 81.7% | 14.92M▲ 32.9% | 3.03M▼ 79.7% | 6.77M▲ 123.4% | 6.93M▲ 0% |
| Equity Growth % | -86.57% | 715.97% | 4.89% | 285.39% | -23.83% | -81.74% | 32.85% | -79.69% | 123.42% | 1336.97% |
| Book Value per Share | 1.86 | 15.19 | 15.26 | 42.00 | 21.16 | 3.80 | 3.23 | 0.38 | 1.11 | 1.10 |
| Total Shareholders' Equity | 2.45M | 19.98M | 20.95M | 80.75M | 61.51M | 11.23M | 14.92M | 3.03M | 6.77M | 6.93M |
| Common Stock | 17.58M | 4K | 4K | 9K | 9K | 11K | 0 | 0 | 1K | 1K |
| Retained Earnings | -22.6M | -33.62M | -54.99M | -81.3M | -105.97M | -170.07M | -172.65M | -189.56M | -199.26M | -201.31M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -17.58M | 0 | 0 | -27K | 83K | -2K | 0 | 0 | 0 | 102K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XCUR Cash Flow Statement
Exicure, Inc. (XCUR) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -5.05M | -19.79M | -19.49M | 1.32M | -39.27M | -34.82M | -35.66M | -10.36M | -2.91M | -2.91M |
| Operating CF Margin % | -487.45% | -203.61% | -16514.41% | 101.62% | -236.38% | 7208.9% | -123.7% | - | -582% | - |
| Operating CF Growth % | 58.61% | -291.86% | 1.53% | 106.76% | -3081.78% | 11.33% | -2.41% | 70.95% | 71.9% | -1040.12% |
| Net Income | -16.94M | -11.01M | -22.41M | -26.3M | -24.67M | -64.1M | -2.58M | -16.91M | -9.7M | -9.23M |
| Depreciation & Amortization | 180K | 232K | 358K | 724K | 1.45M | 1.78M | 1.86M | 1.38M | 824K | 448K |
| Stock-Based Compensation | 682K | 1.46M | 1.81M | 1.84M | 2.18M | 2.94M | 1.37M | 1.35M | 22K | 7K |
| Deferred Taxes | 67K | -214K | 274K | -386K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 260K | -25K | 496K | 228K | 99K | 460K | 514K | 2.92M | 5.31M | -308K |
| Working Capital Changes | 10.77M | -10.45M | -11K | 25.21M | -18.33M | 24.11M | -36.81M | 914K | 631K | 829K |
| Change in Receivables | 237K | -13K | 10K | -32K | 24K | 11K | 0 | 0 | -506K | 2.29M |
| Change in Inventory | 1.35M | -2.35M | 775K | -372K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -126K | 195K | -557K | 789K | 364K | 1.58M | -3.05M | 1.27M | -193K | -127K |
| Cash from Investing | -394K | -926K | -94K | -63.43M | 10.14M | 43.09M | 4.7M | -1.08M | 0 | -2.26M |
| Capital Expenditures | -394K | -926K | -94K | -1.08M | -3.17M | -968K | -10K | 0 | 0 | -214K |
| CapEx % of Revenue | 38.03% | 9.53% | 79.66% | 83.49% | 19.09% | -200.41% | 0.03% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.05M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 205K | 922K | 0 | 0 |
| Cash from Financing | 6.34M | 26.86M | 20.09M | 84.31M | 15.13M | 1.12M | -3.1M | 3.67M | 13.4M | 14M |
| Debt Issued (Net) | 6M | -1M | 0 | 0 | 12.5M | -10M | -7.5M | 0 | 1M | 0 |
| Equity Issued (Net) | 450K | 31.51M | 22M | 90.75M | 2.97M | 11.48M | 5.04M | 5.44M | 12.4M | 14M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -114K | -3.66M | -1.92M | -6.44M | -344K | -362K | -645K | -1.77M | 0 | 0 |
| Net Change in Cash | 892K▲ 0% | 6.14M▲ 588.5% | 504K▼ 91.8% | 22.19M▲ 4303.2% | -14M▼ 163.1% | 9.38M▲ 167.0% | -34.07M▼ 463.1% | -7.76M▲ 77.2% | 10.49M▲ 235.2% | 3.49M▲ 0% |
| Free Cash Flow | -5.44M▲ 0% | -20.71M▼ 280.5% | -19.58M▲ 5.5% | 235K▲ 101.2% | -42.44M▼ 18160.0% | -35.79M▲ 15.7% | -35.67M▲ 0.3% | -10.36M▲ 71.0% | -2.91M▲ 71.9% | -8.47M▲ 0% |
| FCF Margin % | -525.48% | -213.14% | -16594.07% | 18.13% | -255.47% | 7409.32% | -123.74% | - | -582% | - |
| FCF Growth % | 55.43% | -280.51% | 5.47% | 101.2% | -18160% | 15.68% | 0.33% | 70.96% | 71.9% | -193.89% |
| FCF per Share | -4.14 | -15.75 | -14.26 | 0.12 | -14.60 | -12.12 | -7.72 | -1.29 | -0.48 | -0.48 |
| FCF Conversion (FCF/Net Income) | 0.30x | 1.80x | 0.87x | -0.05x | 1.59x | 0.54x | 13.81x | 0.61x | 0.30x | 0.92x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XCUR Key Ratios
Exicure, Inc. (XCUR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -163.86% | -98.21% | -109.53% | -51.73% | -34.68% | -176.25% | -19.74% | -188.43% | -197.92% | -108.76% |
| Return on Invested Capital (ROIC) | - | - | - | -107.29% | -42.1% | -211.6% | -55.21% | -99.84% | -202.09% | -202.09% |
| Gross Margin | -1218.44% | -34.58% | -11865.25% | 100% | -93.19% | 100% | 93.56% | - | 100% | - |
| Net Margin | -1635.23% | -113.29% | -18994.07% | -2029.55% | -148.49% | 13271.64% | -8.96% | - | -1940.2% | - |
| Debt / Equity | 2.31x | 0.24x | 0.24x | 0.07x | 0.40x | 1.31x | 0.49x | 2.20x | 0.88x | 0.88x |
| Interest Coverage | -22.32x | -13.09x | -32.47x | -33.86x | -44.39x | -36.99x | -3.08x | - | -679.56x | - |
| FCF Conversion | 0.30x | 1.80x | 0.87x | -0.05x | 1.59x | 0.54x | 13.81x | 0.61x | 0.30x | 0.92x |
| Revenue Growth | -56.62% | 838.13% | -98.79% | 998.31% | 1181.87% | -102.91% | 6068.12% | -100% | - | -100% |
XCUR Frequently Asked Questions
Exicure, Inc. (XCUR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Exicure, Inc. (XCUR) reported $0.5M in revenue for fiscal year 2024. This represents a 79% decrease from $2.4M in 2015.
Exicure, Inc. (XCUR) grew revenue by 0.0% over the past year. Growth has been modest.
Exicure, Inc. (XCUR) reported a net loss of $9.2M for fiscal year 2024.
Dividend & Returns
Exicure, Inc. (XCUR) has a return on equity (ROE) of -197.9%. Negative ROE indicates the company is unprofitable.
Exicure, Inc. (XCUR) had negative free cash flow of $8.5M in fiscal year 2024, likely due to heavy capital investments.
Explore More XCUR
Exicure, Inc. (XCUR) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates